Search Results - "Kollman, Craig"

A Randomized Trial of Closed-Loop Control in Children with Type 1 Diabetes by Breton, Marc D, Kanapka, Lauren G, Beck, Roy W, Ekhlaspour, Laya, Forlenza, Gregory P, Cengiz, Eda, Schoelwer, Melissa, Ruedy, Katrina J, Jost, Emily, Carria, Lori, Emory, Emma, Hsu, Liana J, Oliveri, Mary, Kollman, Craig C, Dokken, Betsy B, Weinzimer, Stuart A, DeBoer, Mark D, Buckingham, Bruce A, Cherñavvsky, Daniel, Wadwa, R. Paul

“…A closed-loop system (also called an artificial pancreas) may improve glycemic outcomes in children with type 1 diabetes. In this 16-week trial, the glucose…”
Get full text

Validation of Time in Range as an Outcome Measure for Diabetes Clinical Trials by Beck, Roy W, Bergenstal, Richard M, Riddlesworth, Tonya D, Kollman, Craig, Li, Zhaomian, Brown, Adam S, Close, Kelly L

“…This study evaluated the association of time in range (TIR) of 70-180 mg/dL (3.9-10 mmol/L) with the development or progression of retinopathy and development…”
Get full text

The Relationships Between Time in Range, Hyperglycemia Metrics, and HbA1c by Beck, Roy W., Bergenstal, Richard M., Cheng, Peiyao, Kollman, Craig, Carlson, Anders L., Johnson, Mary L., Rodbard, David

“…Background: As the use of continuous glucose monitoring (CGM) increases, there is a need to better understand key metrics of time in range 70-180 mg/dL…”
Get full text

The effect of donor characteristics on survival after unrelated donor transplantation for hematologic malignancy by Kollman, Craig, Spellman, Stephen R., Zhang, Mei-Jie, Hassebroek, Anna, Anasetti, Claudio, Antin, Joseph H., Champlin, Richard E., Confer, Dennis L., DiPersio, John F., Fernandez-Viña, Marcelo, Hartzman, Robert J., Horowitz, Mary M., Hurley, Carolyn K., Karanes, Chatchada, Maiers, Martin, Mueller, Carlheinz R., Perales, Miguel-Angel, Setterholm, Michelle, Woolfrey, Ann E., Yu, Neng, Eapen, Mary

“…There are >24 million registered adult donors, and the numbers of unrelated donor transplantations are increasing. The optimal strategy for prioritizing among…”
Get full text

Home Use of Day-and-Night Hybrid Closed-Loop Insulin Delivery in Very Young Children: A Multicenter, 3-Week, Randomized Trial by Tauschmann, Martin, Allen, Janet M, Nagl, Katrin, Fritsch, Maria, Yong, James, Metcalfe, Emily, Schaeffer, Dominique, Fichelle, Muriel, Schierloh, Ulrike, Thiele, Alena G, Abt, Daniela, Kojzar, Harald, Mader, Julia K, Slegtenhorst, Sonja, Barber, Nicole, Wilinska, Malgorzata E, Boughton, Charlotte, Musolino, Gianluca, Sibayan, Judy, Cohen, Nathan, Kollman, Craig, Hofer, Sabine E, Fröhlich-Reiterer, Elke, Kapellen, Thomas M, Acerini, Carlo L, de Beaufort, Carine, Campbell, Fiona, Rami-Merhar, Birgit, Hovorka, Roman

“…We aimed to assess the feasibility and safety of hybrid closed-loop insulin delivery in children with type 1 diabetes aged 1-7 years as well as evaluate the…”
Get full text

Predictive Low-Glucose Insulin Suspension Reduces Duration of Nocturnal Hypoglycemia in Children Without Increasing Ketosis by Buckingham, Bruce A, Raghinaru, Dan, Cameron, Fraser, Bequette, B Wayne, Chase, H Peter, Maahs, David M, Slover, Robert, Wadwa, R Paul, Wilson, Darrell M, Ly, Trang, Aye, Tandy, Hramiak, Irene, Clarson, Cheril, Stein, Robert, Gallego, Patricia H, Lum, John, Sibayan, Judy, Kollman, Craig, Beck, Roy W

“…Nocturnal hypoglycemia can cause seizures and is a major impediment to tight glycemic control, especially in young children with type 1 diabetes. We conducted…”
Get full text

A Randomized Trial of a Home System to Reduce Nocturnal Hypoglycemia in Type 1 Diabetes by MAAHS, David M, CALHOUN, Peter, SLOVER, Robert, PAUL WADWA, R, WILSON, Darrell M, KOLLMAN, Craig, BECK, Roy W, BUCKINGHAM, Bruce A, PETER CHASE, H, HRAMIAK, Irene, LUM, John, CAMERON, Fraser, WAYNE BEQUETTE, B, AYE, Tandy, PAUL, Terri

“…Overnight hypoglycemia occurs frequently in individuals with type 1 diabetes and can result in loss of consciousness, seizure, or even death. We conducted an…”
Get full text

Manual closed-loop insulin delivery in children and adolescents with type 1 diabetes: a phase 2 randomised crossover trial by Hovorka, Roman, Dr, Allen, Janet M, RN, Elleri, Daniela, MD, Chassin, Ludovic J, PhD, Harris, Julie, RN, Xing, Dongyuan, MPH, Kollman, Craig, PhD, Hovorka, Tomas, MSc, Larsen, Anne Mette F, MSc, Nodale, Marianna, MSc, De Palma, Alessandra, MD, Wilinska, Malgorzata E, PhD, Acerini, Carlo L, MD, Dunger, David B, Prof

“…Summary Background Closed-loop systems link continuous glucose measurements to insulin delivery. We aimed to establish whether closed-loop insulin delivery…”
Get full text

Influence of HbA1c and BMI on Lipid Trajectories in Youths and Young Adults With Type 1 Diabetes by Katz, Michelle L, Kollman, Craig R, Dougher, Carly E, Mubasher, Mohamed, Laffel, Lori M B

“…To assess the influence of HbA and BMI (measured as BMI z score [zBMI]) on LDL, HDL, and non-HDL trajectories as youths with type 1 diabetes age into early…”
Get full text

Predictors of Time-in-Range (70-180 mg/dL) Achieved Using a Closed-Loop Control System by Schoelwer, Melissa J, Kanapka, Lauren G, Wadwa, R Paul, Breton, Marc D, Ruedy, Katrina J, Ekhlaspour, Laya, Forlenza, Gregory P, Cobry, Erin C, Messer, Laurel H, Cengiz, Eda, Jost, Emily, Carria, Lori, Emory, Emma, Hsu, Liana J, Weinzimer, Stuart A, Buckingham, Bruce A, Lal, Rayhan A, Oliveri, Mary Clancy, Kollman, Craig C, Dokken, Betsy B, Cherñavvsky, Daniel R, Beck, Roy W, DeBoer, Mark D

“…Studies of closed-loop control (CLC) in patients with type 1 diabetes (T1D) consistently demonstrate improvements in glycemic control as measured by increased…”
Get more information

The Effect of Donor Diabetes History on Graft Failure and Endothelial Cell Density 10 Years after Penetrating Keratoplasty by Lass, Jonathan H., MD, Riddlesworth, Tonya D., PhD, Gal, Robin L., MSPH, Kollman, Craig, PhD, Benetz, Beth A., MA, Price, Francis W., MD, Sugar, Alan, MD, Terry, Mark A., MD, Soper, Mark, Beck, Roy W., MD, PhD

“…Objective To examine the long-term effect of donor diabetes history on graft failure and endothelial cell density (ECD) after penetrating keratoplasty (PK) in…”
Get full text

Recipient Risk Factors for Graft Failure in the Cornea Donor Study by Sugar, Alan, MD, Tanner, Jean Paul, MPH, Dontchev, Mariya, MPH, Tennant, Brad, BA, Schultze, Robert L., MD, Dunn, Steven P., MD, Lindquist, Thomas D., MD, PhD, Gal, Robin L., MSPH, Beck, Roy W., MD, PhD, Kollman, Craig, PhD, Mannis, Mark J., MD, Holland, Edward J., MD

“…Purpose To identify recipient factors that may be related to risk of corneal graft failure. Design Multicenter, prospective, double-masked, controlled clinical…”
Get full text

Insulin pump use in young children in the T1D Exchange clinic registry is associated with lower hemoglobin A1c levels than injection therapy by Blackman, Scott M, Raghinaru, Dan, Adi, Saleh, Simmons, Jill H, Ebner-Lyon, Laurie, Chase, H Peter, Tamborlane, William V, Schatz, Desmond A, Block, Jennifer M, Litton, Jean C, Raman, Vandana, Foster, Nicole C, Kollman, Craig R, DuBose, Stephanie N, Miller, Kellee M, Beck, Roy W, DiMeglio, Linda A

“…Insulin delivery via injection and continuous subcutaneous insulin infusion (CSII) via insulin pump were compared in a cross‐sectional study (n = 669) and…”
Get full text

Optical Coherence Tomography Measurements and Analysis Methods in Optical Coherence Tomography Studies of Diabetic Macular Edema by Browning, David J., MD, PhD, Glassman, Adam R., MS, Aiello, Lloyd P., MD, PhD, Bressler, Neil M., MD, Bressler, Susan B., MD, Danis, Ronald P., MD, Davis, Matthew D., MD, Ferris, Frederick L., MD, Huang, Suber S., MD, Kaiser, Peter K., MD, Kollman, Craig, PhD, Sadda, Srinavas, MD, Scott, Ingrid U., MD, MPH, Qin, Haijing, MS

“…Objective To evaluate optical coherence tomography (OCT) measurements and methods of analysis of OCT data in studies of diabetic macular edema (DME). Design…”
Get full text

Cost-Effectiveness of Continuous Glucose Monitoring in Type 1 Diabetes by Huang, Elbert S, O'Grady, Michael, Basu, Anirban, Winn, Aaron, John, Priya, Lee, Joyce, Meltzer, David, Kollman, Craig, Laffel, Lori, Tamborlane, William, Weinzimer, Stuart, Wysocki, Tim

“…OBJECTIVE: Continuous glucose monitoring (CGM) has been found to improve glucose control in type 1 diabetic patients. We estimated the cost-effectiveness of…”
Get full text

Diabetic Ketoacidosis at Diabetes Onset: Still an All Too Common Threat in Youth by Klingensmith, Georgeanna J., MD, Tamborlane, William V., MD, Wood, Jamie, MD, Haller, Michael J., MD, Silverstein, Janet, MD, Cengiz, Eda, MD, Shanmugham, Satya, BS, Kollman, Craig, PhD, Wong-Jacobson, Siew, MPH, Beck, Roy W., MD, PhD

“…Objective To define the demographic and clinical characteristics of children at the onset of type 1 diabetes (T1D), with particular attention to the frequency…”
Get full text

Assessing the effect of closed-loop insulin delivery from onset of type 1 diabetes in youth on residual beta-cell function compared to standard insulin therapy (CLOuD study): a randomised parallel study protocol by Boughton, Charlotte, Allen, Janet M, Tauschmann, Martin, Hartnell, Sara, Wilinska, Malgorzata E, Musolino, Gianluca, Acerini, Carlo L, Dunger, Professor David, Campbell, Fiona, Ghatak, Atrayee, Randell, Tabitha, Besser, Rachel, Trevelyan, Nicola, Elleri, Daniela, Northam, Elizabeth, Hood, Korey, Scott, Eleanor, Lawton, Julia, Roze, Stephane, Sibayan, Judy, Kollman, Craig, Cohen, Nate, Todd, John, Hovorka, Roman

“…IntroductionManagement of newly diagnosed type 1 diabetes (T1D) in children and adolescents is challenging for patients, families and healthcare professionals…”
Get full text

Optimal sampling intervals to assess long-term glycemic control using continuous glucose monitoring by Xing, Dongyuan, Kollman, Craig, Beck, Roy W, Tamborlane, William V, Laffel, Lori, Buckingham, Bruce A, Wilson, Darrell M, Weinzimer, Stuart, Fiallo-Scharer, Rosanna, Ruedy, Katrina J

“…The optimal duration and frequency of short-term continuous glucose monitoring (CGM) to reflect long-term glycemia have not been determined. The Juvenile…”
Get more information

Safety and prescribing recommendations for verapamil in newly diagnosed pediatric type 1 diabetes (T1D): The CLVer experience by Ekhlaspour, Laya, Buckingham, Bruce, Bauza, Colleen, Clements, Mark, Forlenza, Gregory P., Neyman, Anna, Norlander, Lisa, Schamberger, Marcus, Sherr, Jennifer L., Bailey, Ryan, Beck, Roy W., Kollman, Craig, Beasley, Shannon, Cobry, Erin, DiMeglio, Linda A., Paprocki, Emily, Van Name, Michelle, Moran, Antoinette

“…To report the safety and side effects associated with taking verapamil for beta-cell preservation in children with newly-diagnosed T1D. Eighty-eight…”
Get full text

HLA-Identical Sibling Compared With 8/8 Matched and Mismatched Unrelated Donor Bone Marrow Transplant for Chronic Phase Chronic Myeloid Leukemia by ARORA, Mukta, WEISDORF, Daniel J, NADEMANEE, Auayporn, MCGLAVE, Philip, HOROWITZ, Mary M, PETERSDORF, Effie W, SPELLMAN, Stephen R, HAAGENSON, Michael D, KLEIN, John P, HURLEY, Carolyn K, SELBY, George B, ANTIN, Joseph H, KERNAN, Nancy A, KOLLMAN, Craig

“…Transplantation of hematopoietic stem cells from an unrelated donor (URD) is an option for many patients who do not have an HLA-identical sibling donor (MSD)…”
Get full text